MONTELUKAST MYLAN
4MG TBL MND 30
| Maximum ex-factory price/Ex-factory price ? | 186,38 CZK |
|---|---|
| Legal basis of maximum ex-factory price/ex-factory price ? | Maximum ex-factory price set by the law. |
Informace o základní úhradě
| Core reimbursement from health insurance ? | 64,08 CZK |
|---|---|
| Maximum reimbursement from health insurance ? | 95,77 CZK |
| Legal basis of reimbursement from health insurance ? | Reimbursement set by the law. |
| Indication restriction of reimbursement ? | Léčba antileukotrieny v monoterapii nebo jako součást kombinace s ostatními kontrolujícími antiastmatiky je hrazena u perzistujících forem bronchiálního astmatu. V případě neúspěchu terapie s antileukotrieny u dospělých do třech měsíců po jejím zahájení, u dětí do 7 let věku do 6 měsíců po jejím zahájení, není další preskripce antileukotrienů hrazena. |
| Prescribing doctor's specialisation ? |
Pneumology and ftizeology, pediatric pneumology Pediatrics, pediatric and adolescent medicine Allergology and clinical immunology |
| Reporting limit ? | L: Product subject to prescription restriction may be prescribed for reimbursement by a health insurer only by a doctor with specialist capacity, stating the professional field in the prescription restriction, who has concluded an agreement on the provision of the relevant health service with the health insurer in respect of the specialist capacity, or another doctor under written authority of the Specialist Doctor. |
| Rough price for the final consumer ? | 279,27 CZK |
| Rough payment for the final consumer (for 1 prescribed package dispensed) ? | 183.5 CZK |
| Eligible extra payment ? | – |
| Eligible extra payment for individuals aged 65 and older ? | – |
cz